UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Journal of clinical oncology, 2008-01, Vol.26 (1), p.76-82

2008

Volltextzugriff (PDF)

Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma

European journal of surgical oncology, 2018-06, Vol.44 (6), p.810-815

2018

Volltextzugriff (PDF)

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

Journal of clinical oncology, 2016-10, Vol.34 (29), p.3518-3528

2016

Volltextzugriff (PDF)

Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)

Journal of clinical oncology, 2019-10, Vol.37 (29), p.2682-2688

2019

Volltextzugriff (PDF)

Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer

Gynecologic oncology, 2023-06, Vol.173, p.49-57

2023

Volltextzugriff (PDF)

Temozolomide for treatment-resistant recurrent meningioma

Neurology, 2004-04, Vol.62 (7), p.1210

2004

Volltextzugriff (PDF)

Early ductal decompression versus conservative management for gallstone pancreatitis with ampullary obstruction : A prospective randomized clinical trial

Annals of surgery, 2006, Vol.243 (1), p.33-40

2006

Volltextzugriff (PDF)

Carditis : A manifestation of gastroesophageal reflux disease

The American journal of surgical pathology, 2001-02, Vol.25 (2), p.245-252

2001

Volltextzugriff (PDF)

560 COMBINATION OF MOLECULAR ALTERATIONS AND SMOKING INTENSITY PREDICTS BLADDER CANCER OUTCOME: A REPORT FROM THE LOS ANGELES CANCER SURVEILLANCE PROGRAM

The Journal of urology, 2012-04, Vol.187 (4), p.e229-e229

2012

Volltextzugriff (PDF)

Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors

American journal of clinical oncology, 2011-02, Vol.34 (1), p.27-31

2011

Volltextzugriff (PDF)

Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy

Urology (Ridgewood, N.J.), 2000-09, Vol.56 (3), p.453-458

2000

Volltextzugriff (PDF)

Potential role of platelet FcγRIIA in collagen-mediated platelet activation associated with atherothrombosis

Atherosclerosis, 2002-10, Vol.164 (2), p.261-267

2002

Volltextzugriff (PDF)

Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions

International journal of gynecological pathology, 2007-07, Vol.26 (3), p.214

2007

Volltextzugriff (PDF)

A phase 1 dose escalation/expansion study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with solid tumors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3026-3026

2023

Volltextzugriff (PDF)

EphrinB2 (B2) expression predicts poor response to PD1/L1 antibodies (Ab) in metastatic urothelial carcinoma (mUC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4575-4575

2023

Volltextzugriff (PDF)

Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence

Surgery, 2001-03, Vol.129 (3), p.267-276

2001

Volltextzugriff (PDF)

Changes in ctDNA levels after MIBG therapy in patients with relapsed or refractory neuroblastoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10012-10012

2021

Volltextzugriff (PDF)

Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4529-4529

2022

Volltextzugriff (PDF)

Increased c-myb mRNA Expression in Barrett's Esophagus and Barrett's-Associated Adenocarcinoma

The Journal of surgical research, 2001-08, Vol.99 (2), p.301-306

2001

Volltextzugriff (PDF)

Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis

Atherosclerosis, 2002-10, Vol.164 (2), p.261-267

2002

Volltextzugriff (PDF)

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer

International journal of colorectal disease, 2002-01, Vol.17 (1), p.46-49

2002

Volltextzugriff (PDF)

Neoplastic meningitis-related encephalopathy: prognostic significance

Neurology, 2004-12, Vol.63 (11), p.2159

2004

Volltextzugriff (PDF)

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer

Journal of the American College of Surgeons, 2005-03, Vol.200 (3), p.336-344

2005

Volltextzugriff (PDF)

Low HER2/ neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer

International journal of radiation oncology, biology, physics, 2002-02, Vol.52 (2), p.397-405

2002

Volltextzugriff (PDF)

Analysis of Telomerase Activity in Ovarian Cystadenomas, Low-Malignant-Potential Tumors, and Invasive Carcinomas

Gynecologic oncology, 1999-09, Vol.74 (3), p.338-345

1999

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(18)
Female
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Adult
(12)
Aged
(12)
Middle Aged
(12)
Male
(10)
Oncology
(8)
Tumors
(8)
Surgery
(7)
Gastroenterology. Liver. Pancreas. Abdomen
(6)
Treatment Outcome
(6)
Aged, 80 And Over
(5)
Other Diseases. Semiology
(4)
Survival Rate
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Disease Progression
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)

Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer

Temozolomide for treatment-resistant recurrent meningioma

Early ductal decompression versus conservative management for gallstone pancreatitis with ampullary obstruction : A prospective randomized clinical trial

Carditis : A manifestation of gastroesophageal reflux disease

560 COMBINATION OF MOLECULAR ALTERATIONS AND SMOKING INTENSITY PREDICTS BLADDER CANCER OUTCOME: A REPORT FROM THE LOS ANGELES CANCER SURVEILLANCE PROGRAM

Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors

Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy

Potential role of platelet FcγRIIA in collagen-mediated platelet activation associated with atherothrombosis

Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions

A phase 1 dose escalation/expansion study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with solid tumors

EphrinB2 (B2) expression predicts poor response to PD1/L1 antibodies (Ab) in metastatic urothelial carcinoma (mUC)

Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence

Changes in ctDNA levels after MIBG therapy in patients with relapsed or refractory neuroblastoma

Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC)

Increased c-myb mRNA Expression in Barrett's Esophagus and Barrett's-Associated Adenocarcinoma

Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer

Neoplastic meningitis-related encephalopathy: prognostic significance

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer

Low HER2/ neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer

Analysis of Telomerase Activity in Ovarian Cystadenomas, Low-Malignant-Potential Tumors, and Invasive Carcinomas

Aktive Filter

Suchergebnisse filtern